Articles Tagged With: COVID-19
-
Antibiotic Use in COVID-19 Patients
Fifty-seven percent of patients with COVID-19 infection treated at 38 hospitals in Michigan received early empiric antibiotics, although researchers documented community-onset bacterial coinfection in only 3.5%.
-
Tool Helps Emergency Providers Better Stratify COVID-19 Patients
The tool is particularly effective at illuminating which patients are at both ends of the severity spectrum, which can be helpful to emergency clinicians as they make their disposition decisions. Still, it is up to clinicians to consider the information provided, and then use their clinical judgment.
-
STI Testing Kits Are a Useful Tool During Pandemic
The authors of a recent study show it is feasible for providers to send patients at-home testing kits for sexually transmitted infections and expect a majority to be returned with samples.
-
Researchers Study Rate of Sexually Transmitted Infections During COVID-19 Pandemic
The United States has seen increasing rates of sexually transmitted infections for the past six years, but it is not yet clear if the trend has continued in 2020.
-
Pandemic Affects Reproductive Health, Highlighting Disparities
The COVID-19 pandemic has placed hardships on women seeking contraceptives and abortion care worldwide. It has been particularly deleterious to vulnerable populations. A shadow pandemic has developed of reproductive health disparities and more barriers to contraception.
-
COVID-19 Increases Need for Case Managers
COVID-19 has spurred myriad changes in hospitals as providers scrambled to adapt to the new normal. That includes new and creative ways to connect and support patients.
-
FDA Answers Audit Questions from Researchers, Industry
The Food and Drug Administration issued new guidance on inspections during the COVID-19 pandemic, as the agency began to resume domestic inspections in July.
-
COVID-19 Pandemic Changed Informed Consent for Biobanking
Researchers have used the 2018 public health surveillance exception to the Common Rule for the first time during the COVID-19 pandemic. In the early weeks of the pandemic, researchers might have overused this exception. Federal agencies approved some protocols involving lines of genetic materials with explicit research purposes, even if these were secondary to the public health surveillance purpose.
-
Tips for Reopening or Closing Research Studies
The 2020 landscape for clinical trials looks different than it did five or 10 years ago. Even before the worldwide disruption in research from the COVID-19 pandemic, there were systemic shifts that have squeezed trials in ways that add pressure to investigators and IRBs.
-
COVID-19 Infection in MS Patients
In a multicenter, retrospective analysis of patients in a multiple sclerosis (MS) registry, the authors described the clinical characteristics and risks associated with severity of complications from COVID-19 infection in patients with MS.